We are N-(3-trimethoxysilylpropyl)aniline CAS:3068-76-6 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Synonyms:N-[3-(Trimethoxysilyl)propyl]aniline; N-Phenylaminopropyltrimethoxysilane; TriMethoxy[3-(phenylaMino)propyl]silane; N-(3-(Trimethoxysilyl)propyl)aniline;
Physical and Chemical Properties:
Index of Refraction:1.506;
Appearance:Yellowish clear liquid
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is an excellent adhesion promoter that can be used in many resin systems. The silane exhibits very good thermal stability and is useful in high temperature applications that are also exposed to moisture.
The secondary amine is useful in systems where only one reaction between resin and silane is desired (such as NCO terminal polymers).
It is also reactive toward epoxy, phenolic, urethane, imide, and melamine resin systems.
Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.21643-42-5 First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.505-10-2 First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.2- (endo-5-norborneno-2,3-dicarboximido) -1,1,3,3- tetrametiluroniohexafluorofosfato CAS:208462-94-6 First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.